BHMT
Betaine--homocysteine S-methyltransferase 1
Also known as: BHMT1, BHMT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q93088
- Gene
- BHMT
- Ensembl
- ENSG00000145692
- Chromosome
- 5
- Canonical length
- 406 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a cytosolic enzyme that catalyzes the conversion of betaine and homocysteine to dimethylglycine and methionine, respectively. Defects in this gene could lead to hyperhomocyst(e)inemia, but such a defect has not yet been observed. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>Q93088|BHMT
1 MPPVGGKKAK KGILERLNAG EIVIGDGGFV FALEKRGYVK AGPWTPEAAV EHPEAVRQLH
61 REFLRAGSNV MQTFTFYASE DKLENRGNYV LEKISGQEVN EAACDIARQV ADEGDALVAG
121 GVSQTPSYLS CKSETEVKKV FLQQLEVFMK KNVDFLIAEY FEHVEEAVWA VETLIASGKP
181 VAATMCIGPE GDLHGVPPGE CAVRLVKAGA SIIGVNCHFD PTISLKTVKL MKEGLEAARL
241 KAHLMSQPLA YHTPDCNKQG FIDLPEFPFG LEPRVATRWD IQKYAREAYN LGVRYIGGCC
301 GFEPYHIRAI AEELAPERGF LPPASEKHGS WGSGLDMHTK PWVRARARKE YWENLRIASG
361 RPYNPSMSKP DGWGVTKGTA ELMQQKEATT EQQLKELFEK QKFKSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BHMT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 1,068 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,068 nTPM
- kidney: 727 nTPM
- urinary bladder: 11 nTPM
- stomach: 3 nTPM
- epididymis: 1.7 nTPM
- duodenum: 1.1 nTPM
Single-cell type
- hepatocytes: 935 nCPM
- proximal tubule cells: 421 nCPM
- urothelial cells: 179 nCPM
- epididymal efferent duct absorptive cells: 78 nCPM
- renal connecting tubule cells: 43 nCPM
- distal convoluted tubule cells: 19 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.7 nTPM
- hippocampal formation: 1 nTPM
- basal ganglia: 0.7 nTPM
- hypothalamus: 0.7 nTPM
- thalamus: 0.7 nTPM
- amygdala: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino-acid betaine catabolic process
- L-methionine salvage
- protein methylation
- 'de novo' L-methionine biosynthetic process
- amino-acid betaine metabolic process
- regulation of homocysteine metabolic process
Molecular functions
- zinc ion binding
- betaine-homocysteine S-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BHMT as an antibody target. Whether an autoantibody or antibody against BHMT could matter depends on whether native BHMT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BHMT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BHMT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...